01.21.25 -- Exciting Areas Of Innovation For Cell Therapies

Optimizing in vitro transcription (IVT) for mRNA is crucial to improving the stability of these molecules and enabling their large-scale production.

Cleanroom systems are purposely designed to simplify the implementation of the aseptic manufacturing space that the industry needs to meet future sterile injectable capacity demand.

Explore effective strategies and cleaning supplies to ensure irregular cleanroom surfaces, such as light switches, door handles, valves, and piping, maintain the same standards as more accessible areas.

Examine open small format tubing in cell and gene therapy labs – and what technologies are on the horizon to help make more sterile connections going forward.

How should you approach building your aseptic processing line? Explore the advantages of using a modular, configurable technology.

Discover how Synthego's proprietary synthetic sgRNA, combined with Lonza’s 4D-Nucleofector®, enabled highly efficient gene editing in resting human CD4+ T cells.

Learn how experts united to develop a highly scalable AAV manufacturing platform, capable of supporting volumes from 1L to 200L and up to 2000L.

Discover how you can achieve higher titers and robust yield with an optimized, end-to-end lentivirus platform, designed to maximize production and quality for the success of your cell or gene therapy.